A simple talk could ease cancer Patients' anxiety
NCT ID NCT07544446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single early meeting with a psycho-oncology counselor can reduce anxiety and depression and improve quality of life in people recently diagnosed with cancer. About 148 patients will be randomly assigned to either receive this counseling plus standard care, or standard care alone. The study was designed with patient input and will track outcomes over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
initial psycho-oncological consultation
What this could lead to
If it works, this could show that a simple early counseling session helps cancer patients feel less anxious and depressed and improves their quality of life.
What could go wrong
This is a small early-stage study (148 participants) testing a behavioral intervention, so results may not apply broadly. The benefit may be small or no different from standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinik für Hämatologie und Onkologie Hirs landen Zürich AG
Zurich, 8032, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lindenhofgruppe
Bern, 3012, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
See-Spital
Horgen, 8810, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St. Claraspital
Basel, 4058, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Insel Gruppe AG
Bern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact